SequelSEC

iSpecimen Inc. ISPC

Services-Commercial Physical & Biological Research · CIK 0001558569 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$151.94K
Fiscal year ended 2026-06-30
Operating income
-$1.36M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

iSpecimen Inc. (ISPC) reported revenue of $151.94K and net income of -$1.36M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from iSpecimen Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Commercial Physical & Biological Research.

Income

iSpecimen Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Revenue$151.94K$156.01K$51.76K$106.59K$713.14K$1.06M$1.48M$2.66M$2.86M$2.29M
Cost of revenue$83.29K$84.41K$598.84K$204.59K$444.18K$657.28K$1.32M$1.55M$1.42M$952.12K
Gross profit$68.65K$71.60K-$547.08K-$98.00K$268.96K$400.23K$151.35K$1.11M$1.44M$1.34M
Operating income-$1.36M-$2.54M-$2.69M-$2.83M-$1.82M-$1.64M-$5.84M-$1.71M-$2.18M-$3.00M
Net income-$1.36M-$2.28M-$5.00M-$2.78M-$1.05M-$1.66M-$6.05M-$1.44M-$2.11M-$2.90M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 1.39MUnavailableUnavailableshares 5.84MUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expenseUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Diluted EPS$-0.98$-6.66Unavailable$-0.48$-16.78$-28.55Unavailable$-2.10$-3.72$-6.36
Selling, general & administrative$986.97K$2.22M$1.45M$2.00M$1.21M$1.11M$4.58M$1.52M$2.14M$2.77M
General & administrative$442.51K$680.42K$901.13K$864.06K$948.38K$758.67K$2.02M$892.71K$1.06M$2.10M
Selling & marketing$544.46K$1.54M$549.08K$1.14M$258.38K$347.14K$2.56M$631.62K$1.08M$665.94K

Balance

iSpecimen Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalents$4.41M$2.82M$6.88MUnavailableUnavailableUnavailable$1.88M$1.75M$2.15M$2.09M
Total assets$7.39M$6.61M$9.53M$9.00M$6.03M$6.84M$9.35M$11.26M$11.90M$12.51M
Current assets$4.48M$3.48M$6.95M$3.60M$1.17M$1.53M$3.59M$4.66M$5.24M$5.29M
Total liabilities$5.66M$5.80M$6.44M$5.92M$5.41M$5.17M$6.04M$6.55M$5.81M$5.70M
Current liabilities$5.48M$5.60M$6.23M$5.70M$5.17M$4.92M$5.77M$6.27M$5.81M$5.70M
Total equity incl. NCI$1.74M$814.04K$3.09M$3.07M$621.97K$1.67M$3.31M$4.71M$6.09M$6.81M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$45.11KUnavailableUnavailableUnavailable
Accounts receivable$21.26K$132.85K$48.30K$120.93K$372.47K$581.65K$1.44M$974.38K$892.81K$437.42K
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$4.67M$4.71M$5.36M$4.77M$4.32M$3.79M$4.20M$4.06M$4.21M$3.56M

Cash flow

iSpecimen Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow-$689.62K-$3.36M-$916.92K-$2.04M-$192.23K-$1.10M-$3.57M-$1.08M-$1.54M-$2.07M
Capital expendituresUnavailableUnavailable$0$0UnavailableUnavailable$7.86K$14.54K$0$9.14K
Investing cash flow$0-$700.00K$0-$1.00MUnavailableUnavailable-$73.06K-$179.95K$295.12K$1.94M
Financing cash flowUnavailableUnavailable$5.02M$5.23MUnavailableUnavailable$3.77M$859.98K$1.31M-$118.86K
Net change in cashUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Stock-based compensation$153$1.03K$1.76K$1.80K$1.80K$15.90K$10.97K$65.14K$79.64K$93.92K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$0$0$52.50K
Depreciation & amortization$201.47K$135.94K$407.73K$457.73K$432.73K$432.71K$548.04K$542.78K$606.74K$596.69K

Derived

iSpecimen Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flowUnavailableUnavailable-$916.92K-$2.04MUnavailableUnavailable-$3.58M-$1.09M-$1.54M-$2.08M
Gross margin45.2%45.9%-1056.9%-91.9%37.7%37.8%10.3%41.6%50.3%58.4%
Operating margin-897.1%-1627.1%-5192.9%-2655.2%-255.4%-154.9%-395.8%-64.1%-76.2%-131.0%
FCF marginUnavailableUnavailable-1771.5%-1909.7%UnavailableUnavailable-242.7%-41.1%-53.8%-90.9%
SBC / revenue0.1%0.7%3.4%1.7%0.3%1.5%0.7%2.4%2.8%4.1%
Current ratio0.82x0.62x1.12x0.63x0.23x0.31x0.62x0.74x0.90x0.93x
Revenue YoY growth-78.7%-85.2%-96.5%-96.0%-75.1%-53.8%-42.7%-4.2%76.2%-22.4%
Net margin-896.9%Unavailable-9662.2%-2608.7%-146.9%Unavailable-409.8%-54.1%UnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailable0.0%0.0%UnavailableUnavailable0.5%0.5%0.0%0.4%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ISPC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-18View SEC filing
10-K · Filed 2026-04-01View SEC filing
10-Q · Filed 2025-11-17View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-19View SEC filing

Companies in the same industry

Reconciliation checks needing review

1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2023-12-31

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.